Last reviewed · How we verify

NCT07419958

Effects of Relaxation Exercises on Fear of Movement, Pain, and Quality of Life in Lumbar Disc Herniation Patients

Completed NA Last updated 19 February 2026
What this trial tests

NA trial testing progressive relaxation exercise in Progressive Relaxation Exercise in 96 participants. Completed in 1 September 2025.

Timeline
1 December 2024
Primary endpoint
1 May 2025
1 September 2025

Quick facts

Lead sponsorHasan Kalyoncu University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment96
Start date1 December 2024
Primary completion1 May 2025
Estimated completion1 September 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Hasan Kalyoncu University

Who can join

Adults 18 to 65, any sex, with Progressive Relaxation Exercise or Hernia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates whether progressive relaxation exercises can reduce fear of movement, pain, and improve quality of life in patients with lumbar disc herniation. Participants are randomly assigned to either a control group receiving standard care or an intervention group performing supervised relaxation exercises in addition to standard care. The exercise program is conducted three times per week for 15 sessions. Outcomes are measured before and after the intervention using validated scales assessing kinesiophobia, pain intensity, disability, and quality of life. The goal is to determine whether adding relaxation exercises provides additional benefits for patients with lumbar disc herniation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of progressive relaxation exercise

Trials testing the same drug.

Other Hasan Kalyoncu University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07419958.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing